Browse
Topics & Collections
Search for a specific
disease or term
—  or  —
Learn more about ACP Smart Medicine

Dynamed

X
This content was provided by DynaMed (dynamed.ebscohost.com). For more information click here.
Last Updated: 4/10/2014  

Screening for Breast Cancer

  • Know that breast cancer is the most common non-skin cancer among women in the U.S.

  • Know that age alone remains the greatest risk factor for breast cancer, and most new breast cancer cases occur in women with no other known risk factors.

  • Recognize that mammography remains the most widely studied breast cancer screening modality and the only available screening modality that has been shown to reduce mortality.

  • Recognize that the best evidence of routine mammographic screening efficacy exists for average-risk women aged 50 to 69 years.

  • Identify patients at increased risk for breast cancer who require tailored screening strategies based on personal history (i.e., thoracic irradiation) or family history (i.e., known or suspected hereditary breast cancer syndromes).

DOI: 10.7326/s369
The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP.
Disclosures:
Teresa Cheng, MD, MSc has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Karen M. Freund, MD, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Sarah E. Caron, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Pamela Ganschow, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Tracy A. Battaglia, MD, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Teresa Cheng, MD, MSc has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Sarah E. Caron, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Elizabeth Karwowski, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
The following editors of ACP Smart Medicine have nothing to disclose: Deborah Korenstein, MD, FACP, Editor in Chief; Richard B. Lynn, MD, FACP, Editor; and Davoren Chick, MD, Editor.
Related Content
Annals of Internal Medicine